Differing Protective Effects of Acellular Pertussis Vaccines in Neonatal and Young Mice in a Murine Model of Respiratory Infection
スポンサーリンク
概要
- 論文の詳細を見る
The protective effects on neonatal (3.5 weeks old) and young mice (7 weeks old) of eight pertussis vaccines prepared from various components at various concentrations were investigated in a murine model of respiratory infection (aerosol challenge model). Neonatal mice were more sensitive than young mice to infection by Bordetella pertussis after aerosol challenge. In young mice with all vaccines, there were significant differences between immunized mice and control mice. The efficacy of vaccines was increased by the inclusion of additional filamentous hemagglutinin (FHA), pertussis toxin (PT), or pertactin (PRN) in the basic vaccine (FHA : PT : PRN, 7 : 2 : 1, w/w). An elevated level of FHA strongly increased the efficacy of the vaccine in young mice. It was, however, more difficult to induce protection against B. pertussis in neonatal mice than in young mice, irrespective of the levels of the various components in the vaccines. Our data suggest that pertussis vaccines are less effective in neonatal mice than in young mice, as assessed by the aerosol challenge model.
- 公益社団法人日本薬学会の論文
- 2002-08-01
著者
-
Nagai Masaaki
第一薬科大学 免疫薬品
-
Nagai Masaaki
Division Of Bacterial Vaccines Research Center For Biologicals The Kitasato Institute
-
Sato Takaaki
Division Of Surgery Tochigi Cancer Center Hospital
-
WATANABE Mineo
Department of Microbiology and Biologics, Daiichi College of Pharmaceutical Sciences
-
Nagai M
Division Of Quality Control Research Center For Biologicals The Kitasato Institute
-
Watanabe Mineo
Division of Bacterial Vaccines, Research Center for Biologicals, The Kitasato Institute
-
Komatsu Eiji
Division of Bacterial Vaccines, Research Center for Biologicals, The Kitasato Institute
-
Sato Takaaki
Division Of Bacterial Vaccines Research Center For Biologicals The Kitasato Institute
-
Watanabe M
Division Of Bacterial Vaccines Research Center For Biologicals The Kitasato Institute:(present Addre
-
Komatsu Eiji
Division Of Bacterial Vaccines Research Center For Biologicals The Kitasato Institute
関連論文
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
- Comparison of Characterization among Bordetella Calmodulin-Like Protein, Bovine Brain Calmodulin and Escherichia coli Acyl-Carrier Protein
- Inhibitory Effect of Acyl-CoA and Acyl-Carnitine Compounds on the Ischemia-Inducing Activity of Bordetella Heat-Labile Toxin in Guinea Pig Skin
- Failure of Smooth Muscle Cells Treated with Collagenase to Respond to Bordetella Heat-Labile Toxin
- Production of Antibody against Calmodulin Which Is a Protein with Poor Antigenicity
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
- Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
- Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
- Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
- Differing Protective Effects of Acellular Pertussis Vaccines in Neonatal and Young Mice in a Murine Model of Respiratory Infection
- Influence of Temperature on the Efficacy of 2-Phenoxyethanol as a Preservative for Adsorbed Diphtheria-Purified Pertussis-Tetanus Combined Vaccine
- Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
- Effect of Acellular Pertussis Vaccine Against Various Strains of Bordetella Pertussis in a Murine Model of Respiratory Infection
- Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer